These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28797784)

  • 1. The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients.
    Hoogland AI; Nelson AM; Small BJ; Hyland KA; Gonzalez BD; Booth-Jones M; Anasetti C; Jacobsen PB; Jim HSL
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1974-1979. PubMed ID: 28797784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.
    Sharafeldin N; Bosworth A; Patel SK; Chen Y; Morse E; Mather M; Sun C; Francisco L; Forman SJ; Wong FL; Bhatia S
    J Clin Oncol; 2018 Feb; 36(5):463-475. PubMed ID: 29252122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
    Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
    Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.
    Smith PJ; Lew M; Lowder Y; Romero K; Thompson JC; Bohannon L; Pittman A; Artica A; Ramalingam S; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Sullivan K; Chao N; Sung AD
    Bone Marrow Transplant; 2022 Jan; 57(1):89-94. PubMed ID: 34667271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission.
    Michelis FV; Atenafu EG; Gupta V; Kim DD; Kuruvilla J; Lipton JH; Loach D; Seftel MD; Uhm J; Alam N; Lambie A; McGillis L; Messner HA
    Bone Marrow Transplant; 2015 Jul; 50(7):907-13. PubMed ID: 25822226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
    Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of allogeneic haemopoietic stem cell transplants at a small New Zealand centre: does size matter?
    Ganly P; Cole S; Trengrove A; Butler A
    Intern Med J; 2014 Jul; 44(7):683-9. PubMed ID: 24750295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
    Oran B; Jimenez AM; De Lima M; Popat UR; Bassett R; Andersson B; Borthakur G; Bashir Q; Chen J; Ciurea SO; Jabbour E; Cortes J; Kebriaei P; Khouri IF; Qazilbash MH; Ravandi F; Rondon G; Lu X; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1405-1412. PubMed ID: 25840338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation.
    Mayo S; Messner HA; Rourke SB; Howell D; Victor JC; Kuruvilla J; Lipton JH; Gupta V; Kim DD; Piescic C; Breen D; Lambie A; Loach D; Michelis FV; Alam N; Uhm J; McGillis L; Metcalfe K
    Bone Marrow Transplant; 2016 Jun; 51(6):841-7. PubMed ID: 26926230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
    Kharfan-Dabaja MA; Al Malki MM; Deotare U; Raj RV; El-Jurdi N; Majhail N; Cherry MA; Bashir Q; Darrah J; Nishihori T; Sibai H; Hamadani M; de Lima M; Gerds AT; Selby G; Qazilbash MH; Forman SJ; Ayala E; Lipton JH; Hari PN; Muzzafar T; Zhang L; Olteanu H; Perkins J; Sokol L; Kumar A; Ahmed S
    Br J Haematol; 2017 Dec; 179(5):781-789. PubMed ID: 28980314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.
    Syrjala KL; Artherholt SB; Kurland BF; Langer SL; Roth-Roemer S; Elrod JB; Dikmen S
    J Clin Oncol; 2011 Jun; 29(17):2397-404. PubMed ID: 21537032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is age a risk factor for cognitive changes following hematopoietic cell transplantation?
    Stratton J; Sylvia A; Hoodin F; Choi SW; Pawarode A; Giordani B; Votruba K
    Bone Marrow Transplant; 2021 Mar; 56(3):567-569. PubMed ID: 32862198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.
    Wallen H; Gooley TA; Deeg HJ; Pagel JM; Press OW; Appelbaum FR; Storb R; Gopal AK
    J Clin Oncol; 2005 May; 23(15):3439-46. PubMed ID: 15824415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.
    Nivison-Smith I; Dodds AJ; Butler J; Bradstock KF; Ma DD; Simpson JM; Szer J
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):302-8. PubMed ID: 21620988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
    Baron F; Storb R; Storer BE; Maris MB; Niederwieser D; Shizuru JA; Chauncey TR; Bruno B; Forman SJ; McSweeney PA; Maziarz RT; Pulsipher MA; Agura ED; Wade J; Sorror M; Maloney DG; Sandmaier BM
    J Clin Oncol; 2006 Sep; 24(25):4150-7. PubMed ID: 16896000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience.
    Aljasem HA; Messner HA; Lipton JH; Kim DDH; Viswabandya A; Thyagu S; Deotare U; Michelis FV
    Eur J Haematol; 2018 Mar; 100(3):308-314. PubMed ID: 29240253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
    Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
    Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.